Martingale Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.4M Sell
41,282
-565
-1% -$252K 0.45% 85
2025
Q1
$20.3M Sell
41,847
-9,360
-18% -$4.54M 0.52% 73
2024
Q4
$20.6M Sell
51,207
-2,120
-4% -$854K 0.5% 71
2024
Q3
$24.8M Sell
53,327
-9,345
-15% -$4.35M 0.57% 62
2024
Q2
$29.4M Sell
62,672
-7,316
-10% -$3.43M 0.64% 49
2024
Q1
$29.3M Sell
69,988
-6,464
-8% -$2.7M 0.58% 61
2023
Q4
$31.1M Sell
76,452
-4,845
-6% -$1.97M 0.64% 51
2023
Q3
$28.3M Sell
81,297
-594
-0.7% -$207K 0.59% 59
2023
Q2
$28.8M Sell
81,891
-1,991
-2% -$701K 0.56% 66
2023
Q1
$26.4M Buy
83,882
+697
+0.8% +$220K 0.51% 79
2022
Q4
$24M Sell
83,185
-2,453
-3% -$708K 0.47% 83
2022
Q3
$24.8M Buy
85,638
+19,586
+30% +$5.67M 0.49% 77
2022
Q2
$18.6M Buy
66,052
+13,356
+25% +$3.76M 0.34% 112
2022
Q1
$13.8M Buy
52,696
+41,677
+378% +$10.9M 0.21% 141
2021
Q4
$2.42M Buy
11,019
+5,687
+107% +$1.25M 0.03% 262
2021
Q3
$968K Sell
5,332
-80,314
-94% -$14.6M 0.01% 516
2021
Q2
$17.3M Sell
85,646
-19,484
-19% -$3.93M 0.2% 151
2021
Q1
$22.6M Buy
105,130
+37,505
+55% +$8.06M 0.26% 133
2020
Q4
$16M Sell
67,625
-60,455
-47% -$14.3M 0.18% 148
2020
Q3
$34.9M Buy
128,080
+42,151
+49% +$11.5M 0.42% 83
2020
Q2
$24.9M Buy
85,929
+71,259
+486% +$20.7M 0.29% 116
2020
Q1
$3.49M Buy
14,670
+9,452
+181% +$2.25M 0.05% 375
2019
Q4
$1.14M Sell
5,218
-5,995
-53% -$1.31M 0.01% 737
2019
Q3
$1.9M Sell
11,213
-2,600
-19% -$441K 0.02% 599
2019
Q2
$2.53M Hold
13,813
0.03% 536
2019
Q1
$2.54M Buy
13,813
+3
+0% +$552 0.03% 542
2018
Q4
$2.29M Sell
13,810
-202
-1% -$33.5K 0.03% 507
2018
Q3
$2.7M Buy
14,012
+3,100
+28% +$598K 0.03% 476
2018
Q2
$1.86M Sell
10,912
-2,195
-17% -$373K 0.02% 571
2018
Q1
$2.14M Sell
13,107
-699
-5% -$114K 0.03% 514
2017
Q4
$2.07M Sell
13,806
-499
-3% -$74.8K 0.03% 528
2017
Q3
$2.18M Buy
14,305
+4,500
+46% +$684K 0.03% 538
2017
Q2
$1.26M Buy
9,805
+299
+3% +$38.5K 0.02% 669
2017
Q1
$1.04M Buy
+9,506
New +$1.04M 0.02% 713